Healthcare-associated versus community-acquired infections: A new challenge for science and society

International Journal of Medical Microbiology

Volumn 300, Issue 6, 2010, Pages 342-345

  Gastmeier, Petra ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Community acquired infections; Healthcare associated infections; MRSA; Multidrug resistant organisms; Research

Indexed keywords

ANTIINFECTIVE AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BEHAVIORAL SCIENCE; BIOMETRY; COMMUNITY ACQUIRED INFECTION; ECONOMICS; GRAM NEGATIVE BACTERIUM; HEALTH CARE FACILITY; HOSPITAL INFECTION; HUMAN; INFECTION; INFORMATION SCIENCE; MEDICAL DECISION MAKING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; PSYCHOLOGY; PUBLIC HEALTH; SCIENCE; SHORT SURVEY; SOCIETY; VANCOMYCIN RESISTANT ENTEROCOCCUS; VETERINARY MEDICINE;

ANIMALS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ENTEROCOCCUS; EUROPE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFECTION CONTROL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RISK FACTORS; VANCOMYCIN RESISTANCE;

EID: 77955560903     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2010.04.007     Document Type: Short Survey

References (34)

1. Aldeyab M., Monnet D., López-Lozano J., Hughes C., Scott M., Kearney M., Magee F.A., McElnay J.C. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time series analysis. J. Antimicrob. Chemother. 2008, 62:593-600.
2. Anonymous Recent trends in antimicrobial resistance among Streptococcus pneumoniae and Staphylococcus aureus isolates: the French experience. Eurosurveillance 2008, 13:pii: 19035.
3. Banqué Navarro M., Huttner B., Harbarth S. Methicillin-resistant Staphylococcus aureus control in the 21st century: beyond the acute care hospital. Curr. Opin. Infect. Dis. 2008, 21:372-379.
4. Beyersmann J., Gastmeier P., Wolkewitz M., Schumacher M. An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J. Clin. Epidemiol. 2008, 61:1216-1221.
5. Bootsma M., Diekmann O., Bonten M. Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5620-5625.
6. Chaberny I., Schwab F., Ziesing S., Suerbaum S., Gastmeier P. Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted time series analysis. J. Antimicrob. Chemother. 2008, 62:1422-1429.
7. Cooper B., Medley G., Stone S., Kibbler C., Cookson B., Roberts J., Duckworth G., Lai R., Ebrahimm S. Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:10223-10228.
8. Ellis M., Griffith M., Dooley D., McLean J., Jorgensen J., Patterson J., Davis K.A., Hawley J.S., Regules J.A., Rivard R.G., Gray P.J., Ceremuga J.M., Dejoseph M.A., Hospenthal D.R. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Antimicrob. Agents Chemother. 2007, 51:3591-3598.
9. Francois P., Harbarth S., Huyghe A., Renzi G., Bento M., Gervaix A., Pittet D., Schrenzel J. Methicillin-resistant Staphylococcus aureus, Geneva, Switzerland, 1993-2005. Emerg. Infect. Dis. 2008, 14:304-307.
10. Gould I., MacKenzie F., MacLennan G., Pacitti D., Watson E., Noble D. Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an intensive care unit. Int. J. Antimicrob. Agents 2007, 29:536-543.
11. Harbarth S., Frankhauser C., Schrenzel J., Christenson J., Gervaz P., Bandiera-Clerc C., Renzi G., Vernaz N., Sax H., Pittet D. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008, 299:1149-1157.
12. Healy C., Hulten K., Palazzi D., Campbell J., Baker C. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin. Infect. Dis. 2004, 39:1460-1466.
13. Helgason K., Jones M., Edwards G. Panton-Valentine leukocidin-positive Staphylococcus aureus and foreign travel. J. Clin. Microbiol. 2008, 46:832-833.
14. Huang S., Yokoe D., Hinrichsen V., Spurchise L., Datta R., Miroshnik I., Platt R. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 2006, 43:971-978.
15. Jevons M. Celbenin-resistant Staphylococcus. BMJ 1961, 1:124-125.
16. Jeyaratnam D., Whitty C., Philips K., Liu D., Orezzi C., Ajoku U., French G.L. Impact of rapid screening tests on acquisition of methicillin resistant Staphylococcus aureus: cluster randomized crossover trail. BMJ 2008, 336:927-930.
17. Kaier K., Hagist C., Frank U., Conrad A., Meyer E. Antimicrobial drug consumption, alcohol-based hand disinfection and methicillin-resistant Staphylococcus aureus-a time series analysis. Infect. Control Hosp. Epidemiol. 2009, 30:346-353. (Title given in PubMed: Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection).
18. Kaier K., Wilson C., Chalkley C., Davey P., Suetens C., Grundmann H., de Kraker M., Schumacher M., Wolkewitz M., Frank U. Health and economic impacts of antibiotic resistance in European hospitals-outlook on the BURDEN project. Infection 2008, 36:492-496.
19. Kaye K., Harris A., Samore M., Carmeli Y. The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infect. Control Hosp. Epidemiol. 2005, 26:346-351.
20. Klevens R., Morrison M., Fridkin S., Reingold A., Petit S., Gershman K., Ray S., Harrison L.H., Lynfield R., Dumyati G., Townes J.M., Craig A.S., Fosheim G., McDougal L.K., Tenover F.C. Spread of community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains in healthcare settings. Emerg. Infect. Dis. 2006, 12:1991-1993.
21. Klevens R., Morrison M., Nadle J., Petit S., Gershman K., Ray S., Harrison L.H., Lynfield R., Dumyati G., Townes J.M., Craig A.S., Zell E.R., Fosheim G.E., McDougal L.K., Carey R.B., Fridkin S.K. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
22. Kritsotakis E., Christidou A., Roumbelaki M., Tselentis Y., Gikas A. The dynamic relationship between antibiotic use and the incidence of vancomycin-resistant Enterococcus: time-series modelling of 7-year surveillance data in a tertiary-care hospital. Clin. Microbiol. Infect. 2008, 14:747-754.
23. Lloyd H. Reservoirs of antimicrobial resistance in pet animals. Clin. Infect. Dis. 2007, 45:148-152.
24. Mahamat A., McKenzie M., Brooker K., Monnet D., Daures J., Gould I. Impact of infection control interventions and antibiotic use on hospital MRSA: a multivariate interrupted time-series analysis. Int. J. Antimicrob. Agents 2007, 30:169-176.
25. Mattner F., Biertz F., Chaberny I., Ziesing S., Gastmeier P. Long-term MRSA persistance determined by MRSA surveillance of subsequent hospital stays. Society of Healthcare of America Annual Meeting 2008.
26. Morgan M. Methicillin-resistant Staphylococcus aureus and animals: zoonosis or humanosis?. J. Antimicrob. Chemother. 2008, 62:1181-1187.
27. Saiman L., O'Keefe M., Graham P., Wu F., Saïd-Salim B., Kreiswirth B., LaSala A., Schlievert P.M., Della-Latta P. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin. Infect. Dis. 2003, 37:1313-1319.
28. Saravolatz L., Markowitz N., Arking L., Pohlod D., Fisher E. Methicillin-resistant Staphylococcus aureus: epidemiologic observations during a community-acquired outbreak. Ann. Intern. Med. 1982, 96:11-16.
29. Schumacher M., Wangler M., Wolkewitz M., Beyersmann J. Attributable mortality due to nosocomial infections. A simple and useful application of multistate models. Methods Infect. Med. 2007, 46:495-500.
30. Silbergeld E., Davis M., Leibler J., Peterson A. One reservoir: redefining the community origins of antimicrobial-resistant infections. Med. Clin. North. Am. 2008, 92:1391-1407.
31. Trick W., Weinstein R., DeMarais P., Tomaska W., Nathan C., McAllister S., Hageman J.C., Rice T.W., Westbrook G., Jarvis W.R. Comparison of routine glove use and contact-isolation precautions to prevent transmission of multidrug-resistant bacteria in a long-term care facility. J. Am. Geriatr. Soc. 2004, 52:2003-2009.
32. Vernaz N., Sax H., Pittet D., Bonnabry P., Schrenzel J., Harbarth S. Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J. Antimicrob. Chemother. 2008, 62:601-607.
33. Wagenlehner F., Naber K., Bambl E., Raab U., Wagenlehner C., Kahlau D., Höller C., Witte W., Weidner W., Lehn N., Harbarth S., Linde H.J. Management of a large healthcare-associated outbreak of Panton-Valentine leucocidin-positive meticillin-resistant Staphylococcus aureus in Germany. J. Hosp. Infect. 2007, 67:114-120.
34. Washer P., Joffe H., Solberg C. Audience readings of media messages about MRSA. J. Hosp. Infect. 2008, 70:42-47.